PT-141 Peptide Therapy
PT-141, also known as Bremelanotide, is a melanocortin receptor agonist. FDA-approved for hypoactive sexual desire disorder in women; researched off-label for male sexual function.
/)
/)
What PT-141 may support
Unlike PDE5 inhibitors (Viagra, Cialis), PT-141 works on the central nervous system rather than on blood flow alone. Researched for desire and arousal alongside or instead of vascular treatments.
Eligibility is assessed in a confidential consultation that covers medical history, current medications, and any cardiovascular concerns. Protocols are conservative and on-demand.
Patient experiences
PDE5 inhibitors weren't covering the desire side. The doctor scoped PT-141 specifically for that. Discreet consultation and clear protocol.
Wanted on-demand, not daily. PT-141 fit the use case. Conservative starting dose and check-in after two months.
Cardiology cleared me first. Doctor coordinated the screening. Felt like a proper medical workup, not a casual prescription.
Our solutions for Weight‑Loss Management
What BPC-157 is studied for
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
/)
What is PT-141?
PT-141, also known as Bremelanotide, is a melanocortin receptor agonist. FDA-approved for hypoactive sexual desire disorder in women; researched off-label for male sexual function.
/)
How PT-141 may work
PT-141 activates melanocortin receptors in the central nervous system. Unlike PDE5 inhibitors, which act on penile blood flow, PT-141 works on desire and arousal pathways upstream.
/)
Who it may be evaluated for
Adult men with desire or arousal concerns, particularly when vascular treatments alone are insufficient. Cardiovascular screening is required.
/)
How Menscape prescribes PT-141
After confidential consultation and cardiology clearance when appropriate, on-demand subcutaneous dosing is set. Conservative starting dose, with follow-up to refine timing.
Doctor-led evaluation
Every PT-141 protocol starts with a full medical consultation and history review.
Licensed compounding pharmacy
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Monthly monitoring
Follow-up consultations every four to six weeks to assess response and safety.
Research-informed positioning
We frame PT-141 as a research-stage peptide and prescribe only when clinically appropriate.
PT-141 questions
How is PT-141 different from Viagra?
Viagra and Cialis are PDE5 inhibitors acting on penile blood flow. PT-141 acts on melanocortin receptors in the brain, affecting desire and arousal upstream.
How is PT-141 administered?
Subcutaneous injection, typically 45 minutes to several hours before activity. Dosing is on-demand, not daily.
What are the side effects?
Most commonly mild nausea, flushing, and transient blood-pressure changes. The doctor screens for cardiovascular risk before prescribing.
Is PT-141 FDA-approved?
Yes, for HSDD (low sexual desire) in pre-menopausal women under the brand Vyleesi. Male use is off-label and doctor-supervised.
Who is not a good candidate?
Patients with uncontrolled hypertension, recent cardiovascular events, severe liver or kidney disease, or known melanocortin-pathway sensitivity. Cardiovascular screening is part of the consultation.
Can PT-141 be used alongside Viagra or Cialis?
In some cases, yes, since they work on different pathways (CNS desire vs. penile blood flow). Combined use requires medical review for cardiovascular risk and timing.
Talk with our medical team about BPC-157
/)